Randy Slemmon

920 total citations · 1 hit paper
15 papers, 521 citations indexed

About

Randy Slemmon is a scholar working on Physiology, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, Randy Slemmon has authored 15 papers receiving a total of 521 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Physiology, 6 papers in Psychiatry and Mental health and 5 papers in Pharmacology. Recurrent topics in Randy Slemmon's work include Alzheimer's disease research and treatments (8 papers), Cholinesterase and Neurodegenerative Diseases (5 papers) and Dementia and Cognitive Impairment Research (5 papers). Randy Slemmon is often cited by papers focused on Alzheimer's disease research and treatments (8 papers), Cholinesterase and Neurodegenerative Diseases (5 papers) and Dementia and Cognitive Impairment Research (5 papers). Randy Slemmon collaborates with scholars based in United States, Germany and Belgium. Randy Slemmon's co-authors include Hartmuth C. Kolb, Gallen Triana‐Baltzer, Marc Mercken, Clara Theunis, Niklas Mattsson, Oskar Hansson, Shorena Janelidze, Jeffrey L. Dage, Sebastian Palmqvist and Xiyun Chai and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Clinical Pharmacokinetics.

In The Last Decade

Randy Slemmon

14 papers receiving 518 citations

Hit Papers

Cerebrospinal fluid p-tau217 performs better than p-tau18... 2020 2026 2022 2024 2020 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease
    2020 292 citations Shorena Janelidze, Erik Stomrud et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Randy Slemmon United States 8 408 245 141 101 91 15 521
Virginia Pérez‐Grijalba Spain 14 541 1.3× 300 1.2× 261 1.9× 126 1.2× 136 1.5× 19 775
Malene Jensen Sweden 10 469 1.1× 278 1.1× 220 1.6× 61 0.6× 89 1.0× 11 616
Luc Bracoud United States 11 410 1.0× 128 0.5× 126 0.9× 149 1.5× 133 1.5× 42 679
Priya Singhal United States 7 320 0.8× 107 0.4× 127 0.9× 143 1.4× 81 0.9× 15 560
Gregory D. Van Vickle United States 6 501 1.2× 133 0.5× 161 1.1× 94 0.9× 170 1.9× 6 608
C M Hulette United States 7 341 0.8× 204 0.8× 155 1.1× 49 0.5× 91 1.0× 10 541
Sangita P. Mehta United States 8 672 1.6× 296 1.2× 272 1.9× 93 0.9× 109 1.2× 11 797
E Van Kerschaver Belgium 4 552 1.4× 336 1.4× 212 1.5× 54 0.5× 123 1.4× 5 682
Josef Pannee Sweden 15 627 1.5× 419 1.7× 306 2.2× 51 0.5× 105 1.2× 22 861
Manuel Maler Germany 5 322 0.8× 125 0.5× 210 1.5× 56 0.6× 62 0.7× 7 433

Countries citing papers authored by Randy Slemmon

Since Specialization
Citations

This map shows the geographic impact of Randy Slemmon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Randy Slemmon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Randy Slemmon more than expected).

Fields of papers citing papers by Randy Slemmon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Randy Slemmon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Randy Slemmon. The network helps show where Randy Slemmon may publish in the future.

Co-authorship network of co-authors of Randy Slemmon

This figure shows the co-authorship network connecting the top 25 collaborators of Randy Slemmon. A scholar is included among the top collaborators of Randy Slemmon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Randy Slemmon. Randy Slemmon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Doré, Vincent, James D. Doecke, Ziad S. Saad, et al.. (2022). Plasma p217+tau versus NAV4694 amyloid and MK6240 tau PET across the Alzheimer's continuum. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 14(1). e12307–e12307. 36 indexed citations
2.
Triana‐Baltzer, Gallen, Maarten Timmers, Peter de Boer, et al.. (2022). Profiling classical neuropsychiatric biomarkers across biological fluids and following continuous lumbar puncture: A guide to sample type and time. SHILAP Revista de lepidopterología. 10. 100116–100116. 2 indexed citations
3.
Triana‐Baltzer, Gallen, Randy Slemmon, Kristof Van Kolen, et al.. (2021). Development and validation of a high‐sensitivity assay for measuring p217+tau in plasma. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 13(1). e12204–e12204. 27 indexed citations
4.
Triana‐Baltzer, Gallen, Kristof Van Kolen, Clara Theunis, et al.. (2020). Development and Validation of a High Sensitivity Assay for Measuring p217 + tau in Cerebrospinal Fluid. Journal of Alzheimer s Disease. 77(4). 1417–1430. 17 indexed citations
5.
Janelidze, Shorena, Erik Stomrud, Ruben Smith, et al.. (2020). Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease. Nature Communications. 11(1). 1683–1683. 292 indexed citations breakdown →
6.
7.
Tong, Gary, Junsheng Wang, Oleksandr Sverdlov, et al.. (2012). Effects of Single Doses of Avagacestat (BMS-708163) on Cerebrospinal Fluid Aβ Levels in Healthy Young Men. Clinical Drug Investigation. 32(11). 761–769. 26 indexed citations
8.
Dockens, Randy, Junsheng Wang, Oleksandr Sverdlov, et al.. (2012). A Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Avagacestat (BMS-708163) in Healthy Young and Elderly Subjects. Clinical Pharmacokinetics. 51(10). 681–693. 36 indexed citations
9.
Tong, Gary, Junsheng Wang, Oleksandr Sverdlov, et al.. (2012). A contrast in safety, pharmacokinetics and pharmacodynamics across age groups after a single 50 mg oral dose of the γ‐secretase inhibitor avagacestat. British Journal of Clinical Pharmacology. 75(1). 136–145. 12 indexed citations
10.
11.
Waring, Jeffrey F., Diane Slats, Celedon Gonzales, et al.. (2011). O1‐04‐02: An assessment of variability in CSF biomarkers in clinical experimental models: a meta‐analysis. Alzheimer s & Dementia. 7(4S_Part_3). 3 indexed citations
12.
Tong, Gary, Shu‐Pang Huang, Randy Slemmon, et al.. (2010). P3‐298: The safety, tolerability, pharmacokinetics and pharmacodynamics of single doses of BMS‐708163 in young and elderly subjects. Alzheimer s & Dementia. 6(4S_Part_17). 2 indexed citations
13.
Tong, Gary, Junsheng Wang, Shu‐Pang Huang, et al.. (2010). O3‐07‐07: A study to evaluate the effects of single oral doses of BMS‐708163 in the cerebrospinal fluid of healthy young men. Alzheimer s & Dementia. 6(4S_Part_5). 6 indexed citations
14.
15.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Virginia Pérez‐Grijalba Breakdown of academic impact, for papers by Malene Jensen Breakdown of academic impact, for papers by Luc Bracoud Breakdown of academic impact, for papers by Priya Singhal Breakdown of academic impact, for papers by Gregory D. Van Vickle Breakdown of academic impact, for papers by C M Hulette Breakdown of academic impact, for papers by Sangita P. Mehta Breakdown of academic impact, for papers by E Van Kerschaver Breakdown of academic impact, for papers by Josef Pannee Breakdown of academic impact, for papers by Manuel Maler
Rankless by CCL
2026